Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Caring.

Rhode Island medical journal

Goldowsky SJ.
PMID: 3456626
R I Med J. 1986 Jan;69(1):15.

No abstract available.

Cite
Goldowsky SJ. Caring. R I Med J. 1986;69(1):15
Goldowsky, S. J. (1986). Caring. Rhode Island medical journal, 69(1), 15.
Goldowsky, S J. "Caring." Rhode Island medical journal vol. 69,1 (1986): 15.
Goldowsky SJ. Caring. R I Med J. 1986 Jan;69(1):15. PMID: 3456626.
Copy Download .nbib Format: NLM
New horizons in cancer research.

Rhode Island medical journal

Goldowsky SJ.
PMID: 3863222
R I Med J. 1985 Aug;68(8):353-4.

No abstract available.

Cite
Goldowsky SJ. New horizons in cancer research. R I Med J. 1985;68(8):353-4
Goldowsky, S. J. (1985). New horizons in cancer research. Rhode Island medical journal, 68(8), 353-4.
Goldowsky, S J. "New horizons in cancer research." Rhode Island medical journal vol. 68,8 (1985): 353-4.
Goldowsky SJ. New horizons in cancer research. R I Med J. 1985 Aug;68(8):353-4. PMID: 3863222.
Copy Download .nbib Format: NLM
Smoking in transition.

Rhode Island medical journal

Goldowsky SJ.
PMID: 3368702
R I Med J. 1988 Mar;71(3):91-2.

No abstract available.

Cite
Goldowsky SJ. Smoking in transition. R I Med J. 1988;71(3):91-2
Goldowsky, S. J. (1988). Smoking in transition. Rhode Island medical journal, 71(3), 91-2.
Goldowsky, S J. "Smoking in transition." Rhode Island medical journal vol. 71,3 (1988): 91-2.
Goldowsky SJ. Smoking in transition. R I Med J. 1988 Mar;71(3):91-2. PMID: 3368702.
Copy Download .nbib Format: NLM
The paradox of DRGs.

Rhode Island medical journal

Goldowsky SJ.
PMID: 3109001
R I Med J. 1987 May;70(5):203-4.

No abstract available.

Cite
Goldowsky SJ. The paradox of DRGs. R I Med J. 1987;70(5):203-4
Goldowsky, S. J. (1987). The paradox of DRGs. Rhode Island medical journal, 70(5), 203-4.
Goldowsky, S J. "The paradox of DRGs." Rhode Island medical journal vol. 70,5 (1987): 203-4.
Goldowsky SJ. The paradox of DRGs. R I Med J. 1987 May;70(5):203-4. PMID: 3109001.
Copy Download .nbib Format: NLM
Colorectal Cancer Screening Guidelines Are Primarily Based on Low-Moderate-Quality Evidence.

Digestive diseases and sciences

Weissman S, Goldowsky A, Aziz M, Mehta TI, Sharma S, Lipcsey M, Walradt T, Iqbal U, Elias S, Feuerstein JD.
PMID: 33433802
Dig Dis Sci. 2021 Dec;66(12):4208-4219. doi: 10.1007/s10620-020-06755-9. Epub 2021 Jan 12.

BACKGROUND: Owning to colorectal cancer's (CRC) high mortality, multiple societies developed screening guidelines.AIMS: We aimed to assess the overall quality of CRC screening guidelines.METHODS: A systematic search was performed to review CRC screening guidelines for conflicts of interest (COI),...

Cite
Weissman S, Goldowsky A, Aziz M, et al. Colorectal Cancer Screening Guidelines Are Primarily Based on Low-Moderate-Quality Evidence. Dig Dis Sci. 2021;66(12):4208-4219doi: 10.1007/s10620-020-06755-9.
Weissman, S., Goldowsky, A., Aziz, M., Mehta, T. I., Sharma, S., Lipcsey, M., Walradt, T., Iqbal, U., Elias, S., & Feuerstein, J. D. (2021). Colorectal Cancer Screening Guidelines Are Primarily Based on Low-Moderate-Quality Evidence. Digestive diseases and sciences, 66(12), 4208-4219. https://doi.org/10.1007/s10620-020-06755-9
Weissman, Simcha, et al. "Colorectal Cancer Screening Guidelines Are Primarily Based on Low-Moderate-Quality Evidence." Digestive diseases and sciences vol. 66,12 (2021): 4208-4219. doi: https://doi.org/10.1007/s10620-020-06755-9
Weissman S, Goldowsky A, Aziz M, Mehta TI, Sharma S, Lipcsey M, Walradt T, Iqbal U, Elias S, Feuerstein JD. Colorectal Cancer Screening Guidelines Are Primarily Based on Low-Moderate-Quality Evidence. Dig Dis Sci. 2021 Dec;66(12):4208-4219. doi: 10.1007/s10620-020-06755-9. Epub 2021 Jan 12. PMID: 33433802.
Copy Download .nbib Format: NLM
P033 Moving the Needle on Speaker Diversity at AIBD.

The American journal of gastroenterology

Goldowsky A, Singh R, Charabaty A, Moss AC.
PMID: 35006161
Am J Gastroenterol. 2021 Dec 01;116:S8. doi: 10.14309/01.ajg.0000798732.38938.e9.

BACKGROUND: Diversity of invited speakers at academic conferences is a topic of increased focus in recent years. While there have been efforts to improve speaker diversity, an evaluation of this in the IBD field has not been undertaken to...

Cite
Goldowsky A, Singh R, Charabaty A, et al. P033 Moving the Needle on Speaker Diversity at AIBD. Am J Gastroenterol. 2021;116:S8doi: 10.14309/01.ajg.0000798732.38938.e9.
Goldowsky, A., Singh, R., Charabaty, A., & Moss, A. C. (2021). P033 Moving the Needle on Speaker Diversity at AIBD. The American journal of gastroenterology, 116S8. https://doi.org/10.14309/01.ajg.0000798732.38938.e9
Goldowsky, Alexander, et al. "P033 Moving the Needle on Speaker Diversity at AIBD." The American journal of gastroenterology vol. 116 (2021): S8. doi: https://doi.org/10.14309/01.ajg.0000798732.38938.e9
Goldowsky A, Singh R, Charabaty A, Moss AC. P033 Moving the Needle on Speaker Diversity at AIBD. Am J Gastroenterol. 2021 Dec 01;116:S8. doi: 10.14309/01.ajg.0000798732.38938.e9. PMID: 35006161.
Copy Download .nbib Format: NLM
P033 Moving the Needle on Speaker Diversity at AIBD.

The American journal of gastroenterology

Goldowsky A, Singh R, Charabaty A, Moss AC.
PMID: 35006161
Am J Gastroenterol. 2021 Dec 01;116:S8. doi: 10.14309/01.ajg.0000798732.38938.e9.

BACKGROUND: Diversity of invited speakers at academic conferences is a topic of increased focus in recent years. While there have been efforts to improve speaker diversity, an evaluation of this in the IBD field has not been undertaken to...

Cite
Goldowsky A, Singh R, Charabaty A, et al. P033 Moving the Needle on Speaker Diversity at AIBD. Am J Gastroenterol. 2021;116:S8doi: 10.14309/01.ajg.0000798732.38938.e9.
Goldowsky, A., Singh, R., Charabaty, A., & Moss, A. C. (2021). P033 Moving the Needle on Speaker Diversity at AIBD. The American journal of gastroenterology, 116S8. https://doi.org/10.14309/01.ajg.0000798732.38938.e9
Goldowsky, Alexander, et al. "P033 Moving the Needle on Speaker Diversity at AIBD." The American journal of gastroenterology vol. 116 (2021): S8. doi: https://doi.org/10.14309/01.ajg.0000798732.38938.e9
Goldowsky A, Singh R, Charabaty A, Moss AC. P033 Moving the Needle on Speaker Diversity at AIBD. Am J Gastroenterol. 2021 Dec 01;116:S8. doi: 10.14309/01.ajg.0000798732.38938.e9. PMID: 35006161.
Copy Download .nbib Format: NLM
Are Quality Metrics in Inflammatory Bowel Disease Rooted on Substantial Quality Evidence? A Systematic Review.

Journal of Crohn's & colitis

Weissman S, Goldowsky A, Mehta TI, Sciarra MA, Feuerstein JD.
PMID: 32544248
J Crohns Colitis. 2020 Jun 16; doi: 10.1093/ecco-jcc/jjaa123. Epub 2020 Jun 16.

BACKGROUND AND AIMS: Quality metrics were established to develop standards to help assess quality of care, yet variation in inflammatory bowel disease (IBD) clinical practice exists. We performed a systematic review to assess the overall quality of evidence cited...

Cite
Weissman S, Goldowsky A, Mehta TI, et al. Are Quality Metrics in Inflammatory Bowel Disease Rooted on Substantial Quality Evidence? A Systematic Review. J Crohns Colitis. 2020;doi: 10.1093/ecco-jcc/jjaa123.
Weissman, S., Goldowsky, A., Mehta, T. I., Sciarra, M. A., & Feuerstein, J. D. (2020). Are Quality Metrics in Inflammatory Bowel Disease Rooted on Substantial Quality Evidence? A Systematic Review. Journal of Crohn's & colitis, . https://doi.org/10.1093/ecco-jcc/jjaa123
Weissman, Simcha, et al. "Are Quality Metrics in Inflammatory Bowel Disease Rooted on Substantial Quality Evidence? A Systematic Review." Journal of Crohn's & colitis vol. (2020). doi: https://doi.org/10.1093/ecco-jcc/jjaa123
Weissman S, Goldowsky A, Mehta TI, Sciarra MA, Feuerstein JD. Are Quality Metrics in Inflammatory Bowel Disease Rooted on Substantial Quality Evidence? A Systematic Review. J Crohns Colitis. 2020 Jun 16; doi: 10.1093/ecco-jcc/jjaa123. Epub 2020 Jun 16. PMID: 32544248.
Copy Download .nbib Format: NLM
BLOOD--"TAKETH AWAY, OR GIVETH".

Rhode Island medical journal

GOLDOWSKY SJ.
PMID: 14199674
R I Med J. 1964 Oct;47:496-7.

No abstract available.

Cite
GOLDOWSKY SJ. BLOOD--"TAKETH AWAY, OR GIVETH". R I Med J. 1964;47:496-7
GOLDOWSKY, S. J. (1964). BLOOD--"TAKETH AWAY, OR GIVETH". Rhode Island medical journal, 47496-7.
GOLDOWSKY, S J. "BLOOD--"TAKETH AWAY, OR GIVETH"." Rhode Island medical journal vol. 47 (1964): 496-7.
GOLDOWSKY SJ. BLOOD--"TAKETH AWAY, OR GIVETH". R I Med J. 1964 Oct;47:496-7. PMID: 14199674.
Copy Download .nbib Format: NLM
Is there a standardized practice for the development of international ulcerative colitis and Crohn's disease treatment guidelines?.

Gastroenterology report

Goldowsky A, Sen R, Hoffman G, Feuerstein JD.
PMID: 34733526
Gastroenterol Rep (Oxf). 2021 Mar 29;9(5):408-417. doi: 10.1093/gastro/goab009. eCollection 2021 Oct.

BACKGROUND: Guidelines are published by international gastroenterology societies regarding the management of ulcerative colitis (UC) and Crohn's disease (CD) to help clinicians to provide high-quality patient care. We examined the guidelines for the quality and strength of evidence used...

Cite
Goldowsky A, Sen R, Hoffman G, et al. Is there a standardized practice for the development of international ulcerative colitis and Crohn's disease treatment guidelines?. Gastroenterol Rep (Oxf). 2021;9(5):408-417doi: 10.1093/gastro/goab009.
Goldowsky, A., Sen, R., Hoffman, G., & Feuerstein, J. D. (2021). Is there a standardized practice for the development of international ulcerative colitis and Crohn's disease treatment guidelines?. Gastroenterology report, 9(5), 408-417. https://doi.org/10.1093/gastro/goab009
Goldowsky, Alexander, et al. "Is there a standardized practice for the development of international ulcerative colitis and Crohn's disease treatment guidelines?." Gastroenterology report vol. 9,5 (2021): 408-417. doi: https://doi.org/10.1093/gastro/goab009
Goldowsky A, Sen R, Hoffman G, Feuerstein JD. Is there a standardized practice for the development of international ulcerative colitis and Crohn's disease treatment guidelines?. Gastroenterol Rep (Oxf). 2021 Mar 29;9(5):408-417. doi: 10.1093/gastro/goab009. eCollection 2021 Oct. PMID: 34733526; PMCID: PMC8560035.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries